1. Home
  2. FF vs RNAC Comparison

FF vs RNAC Comparison

Compare FF & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FutureFuel Corp.

FF

FutureFuel Corp.

HOLD

Current Price

$5.47

Market Cap

212.3M

Sector

Industrials

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$8.19

Market Cap

238.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FF
RNAC
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.3M
238.9M
IPO Year
2005
2016

Fundamental Metrics

Financial Performance
Metric
FF
RNAC
Price
$5.47
$8.19
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$34.00
AVG Volume (30 Days)
358.3K
102.9K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
5.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,797,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$5.60
52 Week High
$6.99
$11.00

Technical Indicators

Market Signals
Indicator
FF
RNAC
Relative Strength Index (RSI) 51.78 39.53
Support Level $5.06 $5.88
Resistance Level $5.55 $9.27
Average True Range (ATR) 0.21 0.60
MACD -0.04 -0.17
Stochastic Oscillator 51.78 6.84

Price Performance

Historical Comparison
FF
RNAC

About FF FutureFuel Corp.

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuels segment sells biodiesel and other petroleum products, with fuels made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment, which generates the majority of revenue, sells products used in the production of agricultural chemicals, including herbicides, as well as coatings and cleaning products such as detergents.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: